Neutralizing human anti-IGFR antibody
The present invention includes fully human, neutralizing, monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1). The antibodies are useful for treating or preventing cancer in a subject. Also included are methods of using and producing the antibodies of the invention.
Schering Corporation
A C C C A A C C A A A C A A C C
A61P C07K C07K C07K A61P A61P C07K C07K A61K A61P A61P C07K A61P A61P C07K C07K
inventional additional additional inventional inventional inventional additional additional additional inventional inventional additional inventional inventional additional inventional
Judith Mohan Robert Yan Peter Denise Jonathan A. Diane Leonard
Hailey Srinivasan Greenberg Wang Brams Williams Pachter Feingersh Presta